Flu Vaccines
Hemispherx Biopharma Initiates Phase IIb Trial in Australia for Ampligen as Vaccine Adjuvant for Seasonal Influenza
Published in TB and Outbreaks Week, July 10th, 2007
Hemispherx Biopharma, Inc. (AMEX: HEB) announced the initiation of a well-controlled Phase IIb trial in Australia of Ampligen(R), an experimental TLR3 ligand shown to function as an immune system activator, in combination with trivalent seasonal influenza vaccine. The trial, expected to last for several months, is occurring in Australia's winter season and focuses on populations at risk for virulent cases of influenza, especially those over the age of 60 years who may lack a robust immune system.
Recently, the Pacific region has received intensified attention by health authorities due to outbreaks of both seasonal and avian influenza and recently issued warnings by the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Obesity and Diabetes
Obesity associated with a lower risk of tuberculosis in older Chinese population - Bird Flu
CIVA Receives Commercialization Grant from Los Alamos Operator for EpiCast - the Revolutionary H5N1 Avian Flu Simulation and Modeling Tool - Epidemic
American Diabetes Association Lauds Chicago Mayor Daley for Recognizing UN Resolution on Diabetes, World Diabetes Day - HIV/AIDS
Abstinence-Only Earmark Removed - HIV/AIDS
Ancient retrovirus sheds light on modern pandemic - HIV/AIDS
Florida: Backward Attitudes, Actions Hamper Response to AIDS Crisis, Says AHF - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
